Kannangai Rajesh, Vivekanandan Perumal, Netski Dale, Mehta Shruti, Kirk Gregory D, Thomas David L, Torbenson Michael
Department of Pathology, The Johns Hopkins School of Medicine, Baltimore, MD 21231, USA.
J Clin Virol. 2007 Jun;39(2):101-5. doi: 10.1016/j.jcv.2007.03.006. Epub 2007 Apr 23.
Occult hepatitis B (HBV) has been reported in numerous clinical settings, but it remains unclear whether occult HBV contributes to liver damage. Given that typical chronic HBV infections often have periodic flairs in viral replication and liver damage, we hypothesized that occult HBV may also have flares in viral replication that are associated with increased liver enzymes.
We screened hepatitis B surface antigen negative injection drug users with untreated chronic hepatitis C viral (HCV) infection for unexplained ALT/AST flares. To further enrich for individuals with possible occult HBV flares, we studied those individuals whose flares were associated with IgM antibodies to hepatitis B core antigen. Serum samples were assayed for HBV DNA and serologies were performed in serum collected 6 months before, at the time, and 6 months after the flare. HCV RNA levels were also determined. Controls consisted of individuals who also had ALT/AST flares but who were negative for IgM antibodies to hepatitis B core antigen.
Seven study cases and eight control cases were identified. HBV DNA was detectable during the enzyme flares in 7/7 study cases versus 3/8 controls, p=0.026. HBV DNA levels during the flare were low, averaging 1943 +/- 2341 copies/ml, but were higher in study cases versus controls, p=0.002. No change in HCV levels was associated with the flares.
In this population at high risk for occult HBV, AST/ALT flares can be associated with detection of HBV DNA. These findings may link occult hepatitis B to liver injury.
隐匿性乙型肝炎病毒(HBV)感染在众多临床环境中均有报道,但隐匿性HBV是否会导致肝损伤仍不清楚。鉴于典型的慢性HBV感染通常在病毒复制和肝损伤方面有周期性发作,我们推测隐匿性HBV在病毒复制方面也可能有发作,且与肝酶升高有关。
我们对未经治疗的慢性丙型肝炎病毒(HCV)感染且乙型肝炎表面抗原阴性的注射吸毒者进行筛查,以寻找不明原因的ALT/AST发作情况。为了进一步富集可能存在隐匿性HBV发作的个体,我们研究了那些发作与乙型肝炎核心抗原IgM抗体相关的个体。在发作前6个月、发作时以及发作后6个月采集的血清样本中检测HBV DNA,并进行血清学检测。同时也测定HCV RNA水平。对照组由同样有ALT/AST发作但乙型肝炎核心抗原IgM抗体阴性的个体组成。
共确定了7例研究病例和8例对照病例。在7/7的研究病例中,酶发作期间可检测到HBV DNA,而对照病例中为3/8,p = 0.026。发作期间HBV DNA水平较低,平均为1943 ± 2341拷贝/毫升,但研究病例中的水平高于对照病例,p = 0.002。发作与HCV水平变化无关。
在这个隐匿性HBV感染高危人群中,AST/ALT发作可能与HBV DNA检测有关。这些发现可能将隐匿性乙型肝炎与肝损伤联系起来。